Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Wednesday, May 31, 2023
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
admin
-
May 17, 2023
Latest Pharma-News
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
admin
-
May 17, 2023
Latest Pharma-News
Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
admin
-
May 9, 2023
Latest Pharma-News
BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
admin
-
May 8, 2023
Latest Pharma-News
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
admin
-
May 8, 2023
Latest Pharma-News
KarXT enrolled in Phase II clinical trial for the treatment of acute psychosis in schizophrenia patients
admin
-
November 20, 2019
0
Latest Pharma-News
TWILIGHT trial showed that Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding compared to dual antiplatelet therapy (DAPT) in patients with non-ST...
admin
-
November 20, 2019
0
Latest Pharma-News
Novartis Phase III PARAGON-HF study: Substantial reductions in heart failure with preserved ejection fraction with Entresto
admin
-
November 19, 2019
0
Latest Pharma-News
Cardiff University’s scientist awarded the funding of £373k to diagnose pancreatic cancer at an earlier stage
admin
-
November 19, 2019
0
Latest Pharma-News
SurVaxM: A novel anti-cancer immunotherapy for the treatment of glioblastoma brain cancers
admin
-
November 19, 2019
0
Latest Pharma-News
Initiation Of First Large-Scale Registry :To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors
admin
-
November 18, 2019
0
Latest Pharma-News
Single, subanesthetic-dose of ketamine infusion relatively free of side effects for patients with treatment-resistant depression
admin
-
November 17, 2019
0
Latest Pharma-News
New Novartis medicine Adakveo® (crizanlizumab) approved by FDA for the treatment of individuals living with sickle cell disease
admin
-
November 17, 2019
0
Latest Pharma-News
BMS and Pfizer to start a new randamized controlled trial accessing the impact of atrial fibrillation screening on health outcomes in older individuals
admin
-
November 17, 2019
0
Latest Pharma-News
FDA approves Talicia To Treat bacterial infection Linked To Stomach Cancer
admin
-
November 17, 2019
0
Latest Pharma-News
Zydus Cadila gets tentative approval from USFDA for Apremilast tablets for the treatment of psoriatic arthritis
admin
-
November 17, 2019
0
Latest Pharma-News
New antibacterial drug approved by FDA to treat complicated urinary tract infections for antimicrobial resistance
admin
-
November 17, 2019
0
1
...
141
142
143
Page 143 of 143
- Advertisment -
Most Read
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
May 17, 2023
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
May 17, 2023
Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
May 9, 2023
BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
May 8, 2023